Phase III Safety and Efficacy Study of ALZT-OP1 in Subjects With Evidence of Early Alzheimer's Disease
Phase of Trial: Phase III
Latest Information Update: 06 Dec 2017
At a glance
- Drugs Ibuprofen (Primary) ; Sodium cromoglicate (Primary)
- Indications Alzheimer's disease
- Focus Registrational; Therapeutic Use
- Acronyms COGNITE
- Sponsors AZTherapies
- 21 Nov 2017 Planned End Date changed from 1 Mar 2018 to 1 Nov 2019.
- 21 Nov 2017 Planned primary completion date changed from 1 Mar 2018 to 1 Nov 2019.
- 31 Oct 2017 According to an AZTherapies media release, over 280 patients have been randomised in the trial till date.